UNSPSC 51422411: Fludroxycortide or flurandrenolide

This classification denotes a therapeutic glucocorticoid with the molecular formula C24H33FO6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8EUL29XUQT, chemically known as 6alpha-fluoro-16alpha-hydroxyhydrocortisone 16,17-acetonide but generally known as fludroxycortide, which bears US NIH Compound Identifier 15209. European Medicines Agency schedules Fludroxycortide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07685MIG.

UNSPSC 51422411 Fludroxycortide or flurandrenolide is a Commodity code that maps poorly to recent state and local procurement activity. The two opportunities tagged under this code involve naloxone and drug deactivation systems (Seminole County, Florida IFB) and a pharmacy benefit management RFI (Texas Health and Human Services Commission), neither of which relates to fludroxycortide, a topical corticosteroid medication. The code shows little relevant recent activity aligned with its pharmaceutical scope.

Seminole County's IFB60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding for quarterly delivery to the Seminole County Community Health Building in Sanford, Florida, with all shipping and delivery costs included in vendor proposals. The Texas HHS Commission's RFI HHS0017013, posted April 3, 2026, gathered market intelligence on direct-to-manufacturer prescription programs for self-insured employee health plans rather than procurement of specific pharmaceutical products. The mismatch between the code's nominal scope and the actual work being solicited suggests that state and local procurement systems may be applying this UNSPSC categorization inconsistently or that the opportunities are miscoded at the source.